Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy.
- DOI
- 10.1136/jitc-2021-002939
- Published
- 2021 Oct
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2021-002939,
title = {Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy.},
author = {Ghonime MG and Saini U and Kelly MC and Roth JC and Wang PY and Chen CY and Miller K and Hernandez-Aguirre I and Kim Y and Mo X and Stanek JR and Cripe T and Mardis E and Cassady KA},
year = {2021},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2021-002939},
url = {https://doi.org/10.1136/jitc-2021-002939}
}RIS
TY - JOUR TI - Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy. AU - Ghonime MG AU - Saini U AU - Kelly MC AU - Roth JC AU - Wang PY AU - Chen CY AU - Miller K AU - Hernandez-Aguirre I AU - Kim Y AU - Mo X AU - Stanek JR AU - Cripe T AU - Mardis E AU - Cassady KA PY - 2021 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2021-002939 UR - https://doi.org/10.1136/jitc-2021-002939 ER -
APA
MG, G., U, S., MC, K., JC, R., PY, W., CY, C., K, M., I, H., Y, K., X, M., JR, S., T, C., E, M., & KA, C. (2021). Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2021-002939
Source records
- pubmed · retrieved 2026-09-25T18:47:47.507Z